Preparation of targeting proteoliposome by postinsertion of a linker molecule conjugated with recombinant human epidermal growth factor

Bioconjugate Chemistry

Volumn 21, Issue 2, 2010, Pages 345-351

  Hwang, Sang Youn ^a   Cho, Do Youn ^a,c   Kim, Hak Kyoung ^a   Cho, Seung Hun ^a,c   Choo, Jaebum ^a   Yoon, Won Joong ^b   Lee, E K ^b  

^a Hanyang University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EFFICIENCY; MOLECULES; PHOSPHOLIPIDS; SURFACE TREATMENT;

ACID CHAINS; BIOFUNCTIONALIZATION; EPIDERMAL GROWTH FACTOR RECEPTORS; EPIDERMAL GROWTH FACTORS; HUMAN EPIDERMAL GROWTH FACTOR; HYDROPHILICS; LINKER MOLECULES; MODIFICATION EFFICIENCY; PROTEOLIPOSOMES; REACTIVE GROUP;

BIOCOMPATIBILITY;

DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; LIPOSOME; NANOPARTICLE; OLEIC ACID; RECOMBINANT EPIDERMAL GROWTH FACTOR;

ARTICLE; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPOPHILICITY; PHOSPHOLIPID BILAYER; PROTEIN FUNCTION; PROTEOLIPOSOME;

EID: 77049108247     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc9004409     Document Type: Article

References (38)

1. Koo, O. M., Rubinstein, I., and Onyuksel, H. (2005) Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 1, 193-212.
2. Bohl Kullberg, E., Bergstrand, N., Carlsson, J., Edwards, K., Johnsson, M., Sjoberg, S., and Gedda, L. (2002) Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents. Bioconjugate Chem. 13, 737-743
3. Bally, M. B., Lim, H., Cullis, P. R., and Mayer, L. D. (1998) Controlling the drug delivery attributes of lipid-based drug formulations. J. Liposome Res. 8, 299-335.
4. Lundberg, B. (1994) The solubilization of lipophilic derivatives of podophyllotoxins in submicron sized lipid emulsions and their cytotoxic activity against cancer-cells in culture. Int. J. Pharmaceut. 09, 73-81.
5. Lundberg, B. B., Griffiths, G., and Hansen, H. J. (2004) Cellular association and cytotoxicity of anti-CD74-targeted lipid drugcarriers in B lymphorna cells. J. Controlled Release 94, 155-161.
6. Torchilin, V. P. (1996) Liposomes as delivery agents for medical imaging. Mol. Med. Today 2, 242-249.
7. Allen, T. M. (1997) Liposomes - Opportunities in drug delivery. Drugs 54, 8-14.
8. Torchilin, V. P. (1998) Polymer-coated long-circulating microparticulate pharmaceuticals. J. Microencapsul. 15, 1-19.
9. Gabizon, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, A., and Barenholz, Y. (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethyleneglycol coated liposomes. Cancer Res. 54, 987-992.
10. Maruyama, K., Yuda, T., Okamoto, A., Kojima, S., Suginaka, A., and Iwatsuru, M. (1992) Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly- (ethylene glycol). Biochim. Biophys. Acta 1128, 44-49
11. Klibanov, A. L., Maruyama, K., Torchilin, V. P., and Huang, L. (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268, 235-237.
12. Allen, T. M., Hansen, C., Martin, F., Redemann, C., and Yauyoung, A. (1991) Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066, 29-36.
13. Fenske, D. B., Palmer, L. R., Chen, T., Wong, K. F., and Cullis, P. R. (2001) Cationic poly(ethyleneglycol) lipids incorporated into pre-formed vesicles enhance binding and uptake to BHK cells. Biochim. Biophys. Acta 1512, 259-272.
14. Nicholas, A. R., Scott, M. J., Kennedy, N. I., and Jones, M. N. (2000) Effect of grafted polyethylene glycol (PEG) on the size, encapsulation efficiency and permeability of vesicles. Biochim. Biophys. Acta 1463, 167-178.
15. Suzuki, S., Watanabe, S., Masuko, T., and Hashimoto, Y. (1995) Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol). Biochim. Biophys. Acta 1245, 9-16.
16. Nam, S. M., Kim, H. S., Ahn, W. S., and Park, Y. S. (1999) Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: Targeting to B16BL6, HRT-18 cancer cells. Oncol. Res. 11, 9-16.
17. Pagnan, G., Montaldo, P. C., Pastorino, F., Raffaghello, L., Kirchmeier, M., Allen, T. M., and Ponzoni, M. (1999) GD2- mediated melanoma cell targeting and cytotoxicity of liposomeentrapped fenretinide. Int. J. Cancer 81, 268-274.
18. Weissig, V., and Gregoriadis, G. (1992) Liposome technology, 2nd ed.; CRC press Inc., Boca Raton.
19. Torchilin, V. P. (2005) Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug DiscoVery 4, 145-160.
20. Hwang, S. Y., Kumada, Y., Seong, G. H., Choo, J., Katoh, S., and Lee, E. K. (2007) Characteristics of a liposome immunoassay on a poly(methyl methacrylate) surface. Anal. Bioanal. Chem. 389, 2251-2257.
21. Messerschmidt, S. K. E., Kolbe, A., Mueller, D., Knoll, M., Pleiss, J., and Kontermann, R. E. (2008) Novel single-chain Fv' formats for the generation of immunoliposomes by site-directed coupling. Bioconjugate Chem. 19, 362-369.
22. Torchilin, V. P., and Weissig, V. (2003) Liposomes: a practical approach, 2nd ed.; Oxford University Press, Oxford.
23. Torchilin, V. P., Trubetskoy, V. S., Milshteyn, A. M., Canillo, J., Wolf, G. L., Papisov, M. I., Bogdanov, A. A., Narula, J., Khaw, B. A., and Omelyanenko, V. G. (1994) Targeted delivery of diagnostic agents by surface-modified liposomes. J. Controlled Release 28, 45-58.
24. Ishida, T., Iden, D. L., and Allen, T. M. (1999) A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett. 460, 129-133.
25. Iden, D. L., and Allen, T. M. (2001) In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim. Biophys. Acta 1513, 207-216.
26. Beuttler, J., Rothdiener, M., Mueller, D., Frejd, F. Y., and Kontermann, R. E. (2009) Targeting of epidermal growth factor receptor (EGFR)-expressing tumor cells with sterically stabilized affibody liposomes (SAL). Bioconjugate Chem. 20, 1201-1208.
27. Steenpass, T., Lung, A., and Schubert, R. (2006) Tresylated PEG-sterols for coupling of proteins to preformed plain or PEGylated liposomes. Biochim. Biophys. Acta 1758, 20-28.
28. Chung, H. A., Kato, K., Itoh, C., Ohhashi, S., and Nagamune, T. (2004) Casual cell surface remodeling using biocompatible lipid-poly(ethylene glycol)(n): Development of stealth cells and monitoring of cell membrane behavior in serum-supplemented conditions. J. Biomed. Mater. Res., Part A 70A, 179-185.
29. Kirby, C., Clarke, J., and Gregoriadis, G. (1980) Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem. J. 186, 591-598
30. Baird, C. L., Courtenay, E. S., and Myszka, D. G. (2002) Surface plasmon resonance characterization of drug/liposome interactions. Anal. Biochem. 310, 93-99.
31. Hynes, N. E., and Stern, D. F. (1994) The biology of Erbb-2 Neu Her-2 and its role in cancer. Biochim. Biophys. Acta 1198, 165-184.
32. Collins, V. P. (1993) Amplified genes in human gliomas. Semin. Cancer Biol. 4, 27-32.
33. Kikuchi, A., Sugaya, S., Ueda, H., Tanaka, K., Aramaki, Y., Hara, T., Arima, H., Tsuchiya, S., and Fuwa, T. (1996) Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes. Biochem. Biophys. Res. Commun. 227, 666-671.
34. Wiley, H. S., Shvartsman, S. Y., and Lauffenburger, D. A. (2003) Computational modeling of the EGF-receptor system: a paradigm for systems biology. Trends Cell Biol. 13, 43-50.
35. Cheung, R. Y., Rauth, A. M., Ronaldson, P. T., Bendayan, R., and Wu, X. Y. (2006) In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin. Eur. J. Pharm. Biopharm. 62, 321-331.
36. Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., and Benz, C. C. (2001) Tumor targeting using anti-her2 immunoliposomes. J. Controlled Release 74, 95-113.
37. Senior, J., and Gregoriadis, G. (1982) Stability of small unilamellar liposomes in serum and clearance from the circulation - the effect of the phospholipid and cholesterol components. Life Sci. 30, 2123-2136.
38. Mamot, C., Drummond, D. C., Greiser, U., Hong, K., Kirpotin, D. B., Marks, J. D., and Park, J. W. (2003) Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res. 63, 3154-3161